Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Nystagmus testing with wearable AR glasses in vertigo patients

Official title: Evaluation of Nystagmus Examinations Conducted Using Wearable Augmented Reality Glasses in Vertigo Patients: A Randomized Equivalence Study

Run by Chang Gung Memorial Hospital · NCT07238387 · Data updated 2026-11-12

This study tests whether wearing AR glasses can match the standard eye-movement exam for classifying central vs peripheral vertigo in adults with dizziness.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations1 site (Kaohsiung, Taiwan)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedJuly 9, 2026
Trial IDNCT07238387 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with vertigo or dizziness suggesting central or peripheral vestibular disorders who can complete both AR and conventional testing in one visit and return for a follow-up.

Probably not a fit

Individuals unable to tolerate the AR headset, with significant ocular or cognitive impairments, or who recently used vestibular-suppressant medications may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center, within-subject randomized equivalence study at Kaohsiung Chang Gung Memorial Hospital. Each participant undergoes both AR-based and conventional oculomotor testing in a randomized order during the same visit, with a 30-minute washout between tests. Independent experts review de-identified test trajectories offline, blinded to modality, to assess diagnostic accuracy and reliability (test-retest and inter-rater). A follow-up visit about one week later collects additional data. The intervention uses wearable AR glasses for nystagmus examination; the comparator is the standard exam performed in a traditional examination room. The study includes adults with vertigo or dizziness who can complete both testing modalities and provide consent, excluding those with recent vestibular-suppressant use, ocular conditions affecting eye tracking, photosensitive conditions, motion sickness, or cognitive limitations that would preclude participation.

Why it matters

Potential benefit: If successful, AR-based testing could enable faster, more portable nystagmus assessment in various settings and improve diagnostic workflow for vertigo.

How similar studies have gone: Previous work in related oculomotor testing has shown promise with AR/tech-enabled assessments, but this exact AR-based nystagmus approach in vertigo is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults ≥18 years with vertigo/dizziness suggestive of a central or peripheral vestibular disorder.
* Able to complete both AR-based and conventional oculomotor testing during the same visit (with \~30-minute washout).
* Provide written informed consent.
* Adequate vision for eye-tracking and calibration (e.g., corrected visual acuity ≥20/40 in each eye).
* Willing and able to return for the follow-up visit.

Exclusion Criteria:

* Use of vestibular-suppressant medications within 24 hours prior to testing (e.g., benzodiazepines, antihistamines, anticholinergics).
* Ocular conditions that would interfere with reliable eye tracking (e.g., corrected visual acuity \<20/40, dense cataract, severe ptosis/strabismus, active ocular infection/inflammation).
* History of photosensitive epilepsy or seizure disorder triggered by visual stimuli.
* Severe motion sickness/cybersickness or inability to tolerate the AR headset.
* Significant cognitive impairment or psychiatric condition precluding informed consent or protocol compliance.
* Pregnant or breastfeeding (per investigator judgment and IRB policy).
* Any other condition that, in the investigator's opinion, would make participation unsafe or confound study results.

Where it's running

  • Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung, Taiwan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.